Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 184 entries
Sorted by: Best Match Show Resources per page
The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers.

Cancers

Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H.
PMID: 30261620
Cancers (Basel). 2018 Sep 26;10(10). doi: 10.3390/cancers10100356.

Oncolytic viral therapy has been accepted as a standard immunotherapy since talimogene laherparepvec (T-VEC, Imlygic

Cite
Eissa IR, Bustos-Villalobos I, Ichinose T, et al. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Cancers (Basel). 2018;10(10)doi: 10.3390/cancers10100356.
Eissa, I. R., Bustos-Villalobos, I., Ichinose, T., Matsumura, S., Naoe, Y., Miyajima, N., Morimoto, D., Mukoyama, N., Zhiwen, W., Tanaka, M., Hasegawa, H., Sumigama, S., Aleksic, B., Kodera, Y., & Kasuya, H. (2018). The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Cancers, 10(10), . https://doi.org/10.3390/cancers10100356
Eissa, Ibrahim Ragab, et al. "The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers." Cancers vol. 10,10 (2018). doi: https://doi.org/10.3390/cancers10100356
Eissa IR, Bustos-Villalobos I, Ichinose T, Matsumura S, Naoe Y, Miyajima N, Morimoto D, Mukoyama N, Zhiwen W, Tanaka M, Hasegawa H, Sumigama S, Aleksic B, Kodera Y, Kasuya H. The Current Status and Future Prospects of Oncolytic Viruses in Clinical Trials against Melanoma, Glioma, Pancreatic, and Breast Cancers. Cancers (Basel). 2018 Sep 26;10(10). doi: 10.3390/cancers10100356. PMID: 30261620; PMCID: PMC6210336.
Copy Download .nbib Format: NLM
Safety and Efficacy of Mini Open Transforaminal Lumbar Interbody Fusion.

Korean Journal of Spine

Mohi Eldin MM, Eissa EM, Elmorsy HM.
PMID: 28127376
Korean J Spine. 2016 Dec;13(4):190-195. doi: 10.14245/kjs.2016.13.4.190. Epub 2016 Dec 31.

OBJECTIVE: Mini-transforaminal lumbar interbody fusion (Mini-TLIF) and other minimally invasive approaches introduced for the purpose of treating lumbar degenerative disc disease and instability are achieving high success and safety rates as the conventional approaches. Moreover, it has less soft...

Cite
Mohi Eldin MM, Eissa EM, Elmorsy HM. Safety and Efficacy of Mini Open Transforaminal Lumbar Interbody Fusion. Korean J Spine. 2016;13(4):190-195doi: 10.14245/kjs.2016.13.4.190.
Mohi Eldin, M. M., Eissa, E. M., & Elmorsy, H. M. (2016). Safety and Efficacy of Mini Open Transforaminal Lumbar Interbody Fusion. Korean Journal of Spine, 13(4), 190-195. https://doi.org/10.14245/kjs.2016.13.4.190
Mohi Eldin, Mohamed M, et al. "Safety and Efficacy of Mini Open Transforaminal Lumbar Interbody Fusion." Korean Journal of Spine vol. 13,4 (2016): 190-195. doi: https://doi.org/10.14245/kjs.2016.13.4.190
Mohi Eldin MM, Eissa EM, Elmorsy HM. Safety and Efficacy of Mini Open Transforaminal Lumbar Interbody Fusion. Korean J Spine. 2016 Dec;13(4):190-195. doi: 10.14245/kjs.2016.13.4.190. Epub 2016 Dec 31. PMID: 28127376; PMCID: PMC5266096.
Copy Download .nbib Format: NLM
Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder.

Frontiers in neuroscience

Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B.
PMID: 29867317
Front Neurosci. 2018 May 16;12:304. doi: 10.3389/fnins.2018.00304. eCollection 2018.

Autistic Spectrum Disorder (ASD) is a complex neurodevelopmental brain disorder characterized by two core behavioral symptoms, namely impairments in social communication and restricted/repetitive behavior. The molecular mechanisms underlying ASD are not well understood. Recent genetic as well as non-genetic...

Cite
Eissa N, Al-Houqani M, Sadeq A, et al. Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. Front Neurosci. 2018;12:304doi: 10.3389/fnins.2018.00304.
Eissa, N., Al-Houqani, M., Sadeq, A., Ojha, S. K., Sasse, A., & Sadek, B. (2018). Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. Frontiers in neuroscience, 12304. https://doi.org/10.3389/fnins.2018.00304
Eissa, Nermin, et al. "Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder." Frontiers in neuroscience vol. 12 (2018): 304. doi: https://doi.org/10.3389/fnins.2018.00304
Eissa N, Al-Houqani M, Sadeq A, Ojha SK, Sasse A, Sadek B. Current Enlightenment About Etiology and Pharmacological Treatment of Autism Spectrum Disorder. Front Neurosci. 2018 May 16;12:304. doi: 10.3389/fnins.2018.00304. eCollection 2018. PMID: 29867317; PMCID: PMC5964170.
Copy Download .nbib Format: NLM
Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair.

International journal of ophthalmology

Nossair AA, Ewais WA, Eissa SA.
PMID: 31024818
Int J Ophthalmol. 2019 Apr 18;12(4):627-633. doi: 10.18240/ijo.2019.04.17. eCollection 2019.

AIM: To evaluate a modified technique for scleral buckling (SB) in pseudophakic retinal detachment (RD).METHODS: A retrospective non-comparative study included 21 consecutive eyes with uncomplicated pseudophakic RD that was repaired by chandelier assisted SB using wide angle viewing (WAV)...

Cite
Nossair AA, Ewais WA, Eissa SA. Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair. Int J Ophthalmol. 2019;12(4):627-633doi: 10.18240/ijo.2019.04.17.
Nossair, A. A., Ewais, W. A., & Eissa, S. A. (2019). Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair. International journal of ophthalmology, 12(4), 627-633. https://doi.org/10.18240/ijo.2019.04.17
Nossair, Ashraf Ahmed, et al. "Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair." International journal of ophthalmology vol. 12,4 (2019): 627-633. doi: https://doi.org/10.18240/ijo.2019.04.17
Nossair AA, Ewais WA, Eissa SA. Chandelier-assisted scleral buckling using wide angle viewing contact lens for pseudophakic retinal detachment repair. Int J Ophthalmol. 2019 Apr 18;12(4):627-633. doi: 10.18240/ijo.2019.04.17. eCollection 2019. PMID: 31024818; PMCID: PMC6469566.
Copy Download .nbib Format: NLM
Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis.

Frontiers in microbiology

Khafipour A, Eissa N, Munyaka PM, Rabbi MF, Kapoor K, Kermarrec L, Khafipour E, Bernstein CN, Ghia JE.
PMID: 32670246
Front Microbiol. 2020 Jun 25;11:1405. doi: 10.3389/fmicb.2020.01405. eCollection 2020.

The pro-inflammatory mediator receptor activator of nuclear factor-kappa B ligand (RANKL) plays a significant role in the development of rheumatoid arthritis; however, its role in inflammatory bowel disease is unknown. Genome-wide association meta-analysis for Crohn's disease (CD) identified a...

Cite
Khafipour A, Eissa N, Munyaka PM, et al. Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis. Front Microbiol. 2020;11:1405doi: 10.3389/fmicb.2020.01405.
Khafipour, A., Eissa, N., Munyaka, P. M., Rabbi, M. F., Kapoor, K., Kermarrec, L., Khafipour, E., Bernstein, C. N., & Ghia, J. E. (2020). Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis. Frontiers in microbiology, 111405. https://doi.org/10.3389/fmicb.2020.01405
Khafipour, Azin, et al. "Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis." Frontiers in microbiology vol. 11 (2020): 1405. doi: https://doi.org/10.3389/fmicb.2020.01405
Khafipour A, Eissa N, Munyaka PM, Rabbi MF, Kapoor K, Kermarrec L, Khafipour E, Bernstein CN, Ghia JE. Denosumab Regulates Gut Microbiota Composition and Cytokines in Dinitrobenzene Sulfonic Acid (DNBS)-Experimental Colitis. Front Microbiol. 2020 Jun 25;11:1405. doi: 10.3389/fmicb.2020.01405. eCollection 2020. PMID: 32670246; PMCID: PMC7331113.
Copy Download .nbib Format: NLM
Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome.

Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Ghozlan MF, Mohamed AAE, Eissa DS, Eldawy HS.
PMID: 30988573
Indian J Hematol Blood Transfus. 2019 Apr;35(2):339-346. doi: 10.1007/s12288-018-1002-5. Epub 2018 Aug 13.

Acute coronary syndrome (ACS) encompasses a range of thrombotic coronary artery diseases. Protein Z (PZ)/PZ-dependent protease inhibitor complex is a natural anticoagulant system with a presumptive role for PZ deficiency in the pathogenesis of ACS. We aimed to evaluate...

Cite
Ghozlan MF, Mohamed AAE, Eissa DS, et al. Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome. Indian J Hematol Blood Transfus. 2018;35(2):339-346doi: 10.1007/s12288-018-1002-5.
Ghozlan, M. F., Mohamed, A. A. E., Eissa, D. S., & Eldawy, H. S. (2019). Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 35(2), 339-346. https://doi.org/10.1007/s12288-018-1002-5
Ghozlan, Manal Fawzy, et al. "Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome." Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion vol. 35,2 (2019): 339-346. doi: https://doi.org/10.1007/s12288-018-1002-5
Ghozlan MF, Mohamed AAE, Eissa DS, Eldawy HS. Low Protein Z Level: A Thrombophilic Risk Biomarker for Acute Coronary Syndrome. Indian J Hematol Blood Transfus. 2019 Apr;35(2):339-346. doi: 10.1007/s12288-018-1002-5. Epub 2018 Aug 13. PMID: 30988573; PMCID: PMC6439042.
Copy Download .nbib Format: NLM
New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and .

Journal of enzyme inhibition and medicinal chemistry

Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS, Elkaeed EB, Eissa IH, Dahab MA, Mahdy HA, Khalifa MM.
PMID: 34961427
J Enzyme Inhib Med Chem. 2022 Dec;37(1):397-410. doi: 10.1080/14756366.2021.2015343.

A new series of benzoxazole derivatives were designed and synthesised to have the main essential pharmacophoric features of VEGFR-2 inhibitors. Cytotoxic activities were evaluated for all derivatives against two human cancer cell lines, MCF-7 and HepG2. Also, the effect...

Cite
Elkady H, Elwan A, El-Mahdy HA, et al. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and . J Enzyme Inhib Med Chem. 2022;37(1):397-410doi: 10.1080/14756366.2021.2015343.
Elkady, H., Elwan, A., El-Mahdy, H. A., Doghish, A. S., Ismail, A., Taghour, M. S., Elkaeed, E. B., Eissa, I. H., Dahab, M. A., Mahdy, H. A., & Khalifa, M. M. (2022). New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and . Journal of enzyme inhibition and medicinal chemistry, 37(1), 397-410. https://doi.org/10.1080/14756366.2021.2015343
Elkady, Hazem, et al. "New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and ." Journal of enzyme inhibition and medicinal chemistry vol. 37,1 (2022): 397-410. doi: https://doi.org/10.1080/14756366.2021.2015343
Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS, Elkaeed EB, Eissa IH, Dahab MA, Mahdy HA, Khalifa MM. New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and . J Enzyme Inhib Med Chem. 2022 Dec;37(1):397-410. doi: 10.1080/14756366.2021.2015343. PMID: 34961427.
Copy Download .nbib Format: NLM
Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors.

Archiv der Pharmazie

El-Adl K, Ibrahim MK, Khedr F, Abulkhair HS, Eissa IH.
PMID: 34596910
Arch Pharm (Weinheim). 2022 Jan;355(1):e2100278. doi: 10.1002/ardp.202100278. Epub 2021 Oct 01.

Twenty new N-substituted-4-phenylphthalazin-1-amine derivatives were designed, synthesized, and evaluated for their anticancer activities against HepG2, HCT-116, and MCF-7 cells as VEGFR-2 inhibitors. HCT-116 was the most sensitive cell line to the influence of the new derivatives. In particular, compound...

Cite
El-Adl K, Ibrahim MK, Khedr F, et al. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch Pharm (Weinheim). 2021;355(1):e2100278doi: 10.1002/ardp.202100278.
El-Adl, K., Ibrahim, M. K., Khedr, F., Abulkhair, H. S., & Eissa, I. H. (2022). Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Archiv der Pharmazie, 355(1), e2100278. https://doi.org/10.1002/ardp.202100278
El-Adl, Khaled, et al. "Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors." Archiv der Pharmazie vol. 355,1 (2022): e2100278. doi: https://doi.org/10.1002/ardp.202100278
El-Adl K, Ibrahim MK, Khedr F, Abulkhair HS, Eissa IH. Design, synthesis, docking, and anticancer evaluations of phthalazines as VEGFR-2 inhibitors. Arch Pharm (Weinheim). 2022 Jan;355(1):e2100278. doi: 10.1002/ardp.202100278. Epub 2021 Oct 01. PMID: 34596910.
Copy Download .nbib Format: NLM
Effect of phosphorus-loaded biochar and nitrogen-fertilization on release kinetic of toxic heavy metals and tomato growth.

International journal of phytoremediation

Ding Z, Alharbi S, Ali EF, Ghoneim AM, Hadi Al Fahd M, Wang G, Eissa MA.
PMID: 34081869
Int J Phytoremediation. 2021 Jun 03;1-10. doi: 10.1080/15226514.2021.1929825. Epub 2021 Jun 03.

In this study, we investigate the effect of nitrogen fertilizer application rates with and without phosphorus-loaded biochar (BCP) on the productivity of tomato (

Cite
Ding Z, Alharbi S, Ali EF, et al. Effect of phosphorus-loaded biochar and nitrogen-fertilization on release kinetic of toxic heavy metals and tomato growth. Int J Phytoremediation. 2021;1-10doi: 10.1080/15226514.2021.1929825.
Ding, Z., Alharbi, S., Ali, E. F., Ghoneim, A. M., Hadi Al Fahd, M., Wang, G., & Eissa, M. A. (2021). Effect of phosphorus-loaded biochar and nitrogen-fertilization on release kinetic of toxic heavy metals and tomato growth. International journal of phytoremediation, 1-10. https://doi.org/10.1080/15226514.2021.1929825
Ding, Zheli, et al. "Effect of phosphorus-loaded biochar and nitrogen-fertilization on release kinetic of toxic heavy metals and tomato growth." International journal of phytoremediation vol. (2021): 1-10. doi: https://doi.org/10.1080/15226514.2021.1929825
Ding Z, Alharbi S, Ali EF, Ghoneim AM, Hadi Al Fahd M, Wang G, Eissa MA. Effect of phosphorus-loaded biochar and nitrogen-fertilization on release kinetic of toxic heavy metals and tomato growth. Int J Phytoremediation. 2021 Jun 03;1-10. doi: 10.1080/15226514.2021.1929825. Epub 2021 Jun 03. PMID: 34081869.
Copy Download .nbib Format: NLM
Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis.

Biomedicines

Eissa N, Elgazzar O, Hussein H, Hendy GN, Bernstein CN, Ghia JE.
PMID: 33535452
Biomedicines. 2021 Feb 01;9(2). doi: 10.3390/biomedicines9020134.

Ulcerative colitis (UC) is characterized by modifying alternatively activated macrophages (AAM) and epithelial homeostasis. Chromogranin-A (CHGA), released by enterochromaffin cells, is elevated in UC and is implicated in inflammation progression. CHGA can be cleaved into several derived peptides, including...

Cite
Eissa N, Elgazzar O, Hussein H, et al. Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis. Biomedicines. 2021;9(2)doi: 10.3390/biomedicines9020134.
Eissa, N., Elgazzar, O., Hussein, H., Hendy, G. N., Bernstein, C. N., & Ghia, J. E. (2021). Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis. Biomedicines, 9(2), . https://doi.org/10.3390/biomedicines9020134
Eissa, Nour, et al. "Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis." Biomedicines vol. 9,2 (2021). doi: https://doi.org/10.3390/biomedicines9020134
Eissa N, Elgazzar O, Hussein H, Hendy GN, Bernstein CN, Ghia JE. Pancreastatin Reduces Alternatively Activated Macrophages, Disrupts the Epithelial Homeostasis and Aggravates Colonic Inflammation. A Descriptive Analysis. Biomedicines. 2021 Feb 01;9(2). doi: 10.3390/biomedicines9020134. PMID: 33535452; PMCID: PMC7912769.
Copy Download .nbib Format: NLM
Synthesis of glycopolymers with specificity for bacterial strains .

Chemical science

Luo Y, Gu Y, Feng R, Brash J, Eissa AM, Haddleton DM, Chen G, Chen H.
PMID: 31191880
Chem Sci. 2019 Apr 18;10(20):5251-5257. doi: 10.1039/c8sc05561k. eCollection 2019 May 28.

Identifying probiotics and pathogens is of great interest to the health of the human body. It is critical to develop microbiota-targeted therapies to have high specificity including strain specificity. In this study, we have utilized

Cite
Luo Y, Gu Y, Feng R, et al. Synthesis of glycopolymers with specificity for bacterial strains . Chem Sci. 2019;10(20):5251-5257doi: 10.1039/c8sc05561k.
Luo, Y., Gu, Y., Feng, R., Brash, J., Eissa, A. M., Haddleton, D. M., Chen, G., & Chen, H. (2019). Synthesis of glycopolymers with specificity for bacterial strains . Chemical science, 10(20), 5251-5257. https://doi.org/10.1039/c8sc05561k
Luo, Yan, et al. "Synthesis of glycopolymers with specificity for bacterial strains ." Chemical science vol. 10,20 (2019): 5251-5257. doi: https://doi.org/10.1039/c8sc05561k
Luo Y, Gu Y, Feng R, Brash J, Eissa AM, Haddleton DM, Chen G, Chen H. Synthesis of glycopolymers with specificity for bacterial strains . Chem Sci. 2019 Apr 18;10(20):5251-5257. doi: 10.1039/c8sc05561k. eCollection 2019 May 28. PMID: 31191880; PMCID: PMC6540911.
Copy Download .nbib Format: NLM
Family, friends, and faith-communities: Intellectual community and the benefits of unofficial networks for marginalized scientists.

History of psychology

Rodkey KL, Rodkey EN.
PMID: 32852966
Hist Psychol. 2020 Nov;23(4):289-311. doi: 10.1037/hop0000172. Epub 2020 Aug 27.

Throughout the 20th century, female scientists faced barriers to participation in scientific communities. Within psychology, the 1st generation of women fought for inclusion in the university and access to laboratories; the 2nd generation officially gained access to such resources...

Cite
Rodkey KL, Rodkey EN. Family, friends, and faith-communities: Intellectual community and the benefits of unofficial networks for marginalized scientists. Hist Psychol. 2020;23(4):289-311doi: 10.1037/hop0000172.
Rodkey, K. L., & Rodkey, E. N. (2020). Family, friends, and faith-communities: Intellectual community and the benefits of unofficial networks for marginalized scientists. History of psychology, 23(4), 289-311. https://doi.org/10.1037/hop0000172
Rodkey, Krista L, and Rodkey, Elissa N. "Family, friends, and faith-communities: Intellectual community and the benefits of unofficial networks for marginalized scientists." History of psychology vol. 23,4 (2020): 289-311. doi: https://doi.org/10.1037/hop0000172
Rodkey KL, Rodkey EN. Family, friends, and faith-communities: Intellectual community and the benefits of unofficial networks for marginalized scientists. Hist Psychol. 2020 Nov;23(4):289-311. doi: 10.1037/hop0000172. Epub 2020 Aug 27. PMID: 32852966.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 184 entries